ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 24 filers reported holding ACURX PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 4.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28 | – | 18,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 500,000 | $750,000 | 0.01% |
| Semmax Financial Advisors Inc. | 5,879 | $20,575 | 0.01% |
| Anchor Investment Management, LLC | 4,500 | $6,750 | 0.00% |
| OSAIC HOLDINGS, INC. | 26,000 | $39,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 88,595 | $126,716 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 14,574 | $20,841 | 0.00% |
| BlackRock Inc. | 18,126 | $27,189 | 0.00% |
| Citadel Advisors | 18,841 | $26,943 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,105 | $15,158 | 0.00% |
| Tower Research Capital LLC (TRC) | 7,097 | $10,646 | 0.00% |